Component

PI4KA (human phosphatidylinositol 4-kinase alpha)

PI4KA (human phosphatidylinositol 4-kinase alpha). Species, exposure and limitations are retained in each linked claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Recombinant human PI4K230, now designated PI4KA, showed phosphatidylinositol 4-kinase activity.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/inositol-research/10101268.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fa5bbd801387ed6401fcba3b21ddc260a21a089c33818db5abcfea346b3db5d0", "start_char": 0, "end_char": 1101, "text_sha256": "fa5bbd801387ed6401fcba3b21ddc260a21a089c33818db5abcfea346b3db5d0"}
    experimental_model
    Recombinant human PI4K230 enzyme characterization
    exposure
    ATP-dependent kinase assays
    limitations
    An enzyme reaction does not establish that free inositol supplementation increases signaling.
    nutrient_topic
    Inositol research collection; topical membership is not evidence of a direct dietary effect. · Inositol (stereoisomer family)
    organism
    Human protein expressed in Sf9 cells
    plain_language
    An enzyme adds a phosphate at position 4 of the PI head group.
    primary_references
    [ino-p10101268] Functional expression and characterisation of a new human phosphatidylinositol 4-kinase PI4K230. (1999). https://pubmed.ncbi.nlm.nih.gov/10101268/ DOI: 10.1016/s1388-1981(99)00029-3
    tissue_or_cell_type
    Recombinant PI4KA

    Inositol: synthesis, signaling, mineral interactions and conditional deficiency (2026-09-17) · lines 561–572

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human PI4K230 enzyme characterization · source_derived_draft · unverified_draft

    ### ino-pi4ka-pi4p Recombinant human PI4K230, now designated PI4KA, showed phosphatidylinositol 4-kinase activity. Condition category: normal nutrient_topic: Inositol research collection; topical membership is not evidence of a direct dietary effect. plain_language: An enzyme adds a phosphate at position 4 of the PI head group. organism: Human protein expressed in Sf9 cells tissue_or_cell_type: Recombinant PI4KA experimental_model: Recombinant human PI4K230 enzyme characterization limitations: An enzyme reaction does not establish that free inositol supplementation increases signaling. exposure: ATP-dependent kinase assays evidence_span: {"source_cache": "artifacts/inositol-research/10101268.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "fa5bbd801387ed6401fcba3b21ddc260a21a089c33818db5abcfea346b3db5d0", "start_char": 0, "end_char": 1101, "text_sha256": "fa5bbd801387ed6401fcba3b21ddc260a21a089c33818db5abcfea346b3db5d0"} [ino-p10101268] Functional expression and characterisation of a new human phosphatidylinositol 4-kinase PI4K230. (1999). https://pubmed.ncbi.nlm.nih.gov/10101268/ DOI: 10.1016/s1388-1981(99)00029-3
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards